3wmg: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
''' | ==Crystal structure of an inward-facing eukaryotic ABC multidrug transporter G277V/A278V/A279V mutant in complex with an cyclic peptide inhibitor, aCAP== | ||
<StructureSection load='3wmg' size='340' side='right' caption='[[3wmg]], [[Resolution|resolution]] 2.40Å' scene=''> | |||
== Structural highlights == | |||
[[3wmg]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3WMG OCA]. <br> | |||
<b>Related:</b> [[3wme|3wme]], [[3wmf|3wmf]]<br> | |||
<b>Activity:</b> <span class='plainlinks'>[http://en.wikipedia.org/wiki/Glucokinase Glucokinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 2.7.1.2] </span><br> | |||
== Publication Abstract from PubMed == | |||
P-glycoprotein is an ATP-binding cassette multidrug transporter that actively transports chemically diverse substrates across the lipid bilayer. The precise molecular mechanism underlying transport is not fully understood. Here, we present crystal structures of a eukaryotic P-glycoprotein homolog, CmABCB1 from Cyanidioschyzon merolae, in two forms: unbound at 2.6-A resolution and bound to a unique allosteric inhibitor at 2.4-A resolution. The inhibitor clamps the transmembrane helices from the outside, fixing the CmABCB1 structure in an inward-open conformation similar to the unbound structure, confirming that an outward-opening motion is required for ATP hydrolysis cycle. These structures, along with site-directed mutagenesis and transporter activity measurements, reveal the detailed architecture of the transporter, including a gate that opens to extracellular side and two gates that open to intramembranous region and the cytosolic side. We propose that the motion of the nucleotide-binding domain drives those gating apparatuses via two short intracellular helices, IH1 and IH2, and two transmembrane helices, TM2 and TM5. | |||
Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog.,Kodan A, Yamaguchi T, Nakatsu T, Sakiyama K, Hipolito CJ, Fujioka A, Hirokane R, Ikeguchi K, Watanabe B, Hiratake J, Kimura Y, Suga H, Ueda K, Kato H Proc Natl Acad Sci U S A. 2014 Mar 3. PMID:24591620<ref>PMID:24591620</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Fujioka, A.]] | |||
[[Category: Hipolito, C J.]] | |||
[[Category: Hirokane, R.]] | |||
[[Category: Hirtake, J.]] | |||
[[Category: Ikeguchi, K.]] | |||
[[Category: Kato, H.]] | |||
[[Category: Kimura, Y.]] | |||
[[Category: Kodan, A.]] | |||
[[Category: Nakatsu, T.]] | |||
[[Category: Sakiyama, K.]] | |||
[[Category: Suga, H.]] | |||
[[Category: Ueda, K.]] | |||
[[Category: Watanabe, B.]] | |||
[[Category: Yamaguchi, T.]] | |||
[[Category: Macrocyclic peptide]] | |||
[[Category: Multi drug transporter]] | |||
[[Category: Rec fold]] | |||
[[Category: Transport protein-inhibitor complex]] | |||
Revision as of 07:48, 30 April 2014
Crystal structure of an inward-facing eukaryotic ABC multidrug transporter G277V/A278V/A279V mutant in complex with an cyclic peptide inhibitor, aCAP
| ||||||||||||